CanadaBuys #WS5872093541

Procurement of Vaccinia Immunoglobulin Intravenous (Human) for PHAC

Public Services and Procurement Canada is seeking to procure vaccinia Immunoglobulin intravenous (human) (VIGIV) for the Public Health Agency of Canada (PHAC). - Government Buyer: - Public Services and Procurement Canada (PSPC) - On behalf of the Public Health Agency of Canada (PHAC) - OEM and Vendor: - Emergent BioSolutions Canada Inc. is the sole manufacturer and vendor mentioned - Products Requested: - Vaccinia Immunoglobulin intravenous (human) (VIGIV) - No specific part numbers or quantities provided - Notable Requirements: - Product is required to protect against complications from smallpox vaccination - Procurement governed by multiple trade agreements - Opportunity available for bidding through SAP Business Network - No unique technical specifications or additional requirements listed

Description

This is an Advanced Contract Award Notice (ACAN) issued by Public Services and Procurement Canada on behalf of the Public Health Agency of Canada (PHAC). The government intends to negotiate a contract for vaccinia Immunoglobulin intravenous (human) (VIGIV) to protect against complications from smallpox vaccination. The contract is intended to be awarded to Emergent BioSolutions Canada Inc. The procurement is governed by multiple trade agreements and is available for bidding through the SAP Business Network with no fees required.

View original listing